Literature DB >> 2708383

Organization and expression of the rat kallikrein gene family.

D R Wines1, J M Brady, D B Pritchett, J L Roberts, R J MacDonald.   

Abstract

We have cloned and characterized eight members of the kallikrein gene family from rat genomic DNA. Three of the cloned genes correspond to the previously characterized kallikrein family mRNAs PS, S2, and P1, which encode true kallikrein, tonin, and a novel kallikrein-like enzyme, respectively. In two cases, two kallikrein family genes are located on single genomic clones, suggesting close linkage of this family in the rat genome. Based on the total number of cloned genes and mRNAs, the minimum size of the rat family is 11 genes. Comparisons between the rat genes demonstrate a high degree of nucleotide sequence identity (greater than 80%) in exonic, intronic, and nearby flanking regions. This extensive sequence conservation not limited to clearly functional domains suggests that concerted evolution of this gene family has occurred. Despite the high overall sequence conservation among the rat family members, several discrete regions of high variability exist in the coding regions. We have defined the tissue-specific expression of the PS (true kallikrein), S2 (tonin), and S3 mRNAs with gene-specific oligonucleotide probes derived from these variant regions. PS is expressed in a wide range of tissues, while S2 mRNA is restricted to the submaxillary gland and S3 mRNA to the submaxillary and prostate glands. The high sequence conservation within the upstream flanking regions of these genes suggests that a small number of nucleotide differences determines the disparate transcriptional specificity of individual family members.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708383

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Characterization of Spink6 in mouse skin: the conserved inhibitor of kallikrein-related peptidases is reduced by barrier injury.

Authors:  Jan Fischer; Zhihong Wu; Tomasz Kantyka; Maria Sperrhacke; Olga Dimitrieva; Yulia Koblyakova; Kerstin Ahrens; Nina Graumann; Hansjörg Baurecht; Karina Reiss; Jens-Michael Schröder; Ehrhardt Proksch; Ulf Meyer-Hoffert
Journal:  J Invest Dermatol       Date:  2013-11-22       Impact factor: 8.551

3.  Identification of tissue kallikrein messenger RNA in human neutrophils.

Authors:  H F Wu; R D Venezie; W M Cohen; J W Jenzano; G L Featherstone; R L Lundblad
Journal:  Agents Actions       Date:  1993-01

4.  Cellular mechanisms of estrogen- and dopamine-induced control of glandular kallikrein in the anterior pituitary of the rat.

Authors:  J P Roa; C A Powers; R Silva; C P Vio
Journal:  Cell Tissue Res       Date:  1993-12       Impact factor: 5.249

5.  Evolution of the rat kallikrein gene family: gene conversion leads to functional diversity.

Authors:  D R Wines; J M Brady; E M Southard; R J MacDonald
Journal:  J Mol Evol       Date:  1991-06       Impact factor: 2.395

6.  Tissue-specific regulation of the expression of rat kallikrein gene family members by thyroid hormone.

Authors:  J A Clements; B A Matheson; J E Funder
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

Review 7.  Development biology of the renal kallikrein-kinin system.

Authors:  S S el-Dahr
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

8.  Molecular cloning, purification and in situ localization of human colon kallikrein.

Authors:  L M Chen; G P Richards; L Chao; J Chao
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

9.  Evolutionary history of tissue kallikreins.

Authors:  Athanasia Pavlopoulou; Georgios Pampalakis; Ioannis Michalopoulos; Georgia Sotiropoulou
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

10.  The solution structure of the kallikrein-related peptidases inhibitor SPINK6.

Authors:  Sascha Jung; Jan Fischer; Björn Spudy; Tim Kerkow; Frank D Sönnichsen; Li Xue; Alexandre M J J Bonvin; Peter Goettig; Viktor Magdolen; Ulf Meyer-Hoffert; Joachim Grötzinger
Journal:  Biochem Biophys Res Commun       Date:  2016-01-30       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.